Lee Kevin Freeman's Insider Trades & SAST Disclosures
Lee Kevin Freeman's most recent trade in Health Catalyst Inc was a trade of 10,800 Common Stock done at an average price of $4.6 . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Lee Kevin Freeman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.58 per share. | 03 Mar 2025 | 10,800 | 384,412 (1%) | 0% | 4.6 | 49,433 | Common Stock |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 140,000 | 376,950 (1%) | 0% | 0 | Common Stock | |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 18,262 | 395,212 (1%) | 0% | 0 | Common Stock | |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.97 per share. | 01 Dec 2024 | 11,431 | 244,450 (0%) | 0% | 9.0 | 102,573 | Common Stock |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.94 per share. | 01 Dec 2024 | 7,500 | 236,950 (0%) | 0% | 8.9 | 67,073 | Common Stock |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 03 Sep 2024 | 7,500 | 255,881 (0%) | 0% | 7.2 | 54,174 | Common Stock |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.27 per share. | 03 Sep 2024 | 2,772 | 263,381 (0%) | 0% | 7.3 | 20,150 | Common Stock |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 6.53 per share. | 11 Jun 2024 | 7,500 | 266,153 (0%) | 0% | 6.5 | 49,008 | Common Stock |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.53 per share. | 03 Jun 2024 | 2,951 | 273,653 (0%) | 0% | 6.5 | 19,280 | Common Stock |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.05 per share. | 01 Mar 2024 | 4,540 | 276,604 (0%) | 0% | 8.1 | 36,552 | Common Stock |
|
Health Catalyst Inc
|
Freeman Kevin Lee | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 110,000 | 277,810 (0%) | 0% | 0 | Common Stock | |
|
Health Catalyst Inc
|
Lee Kevin Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 3,334 | 281,144 (0%) | 0% | 0 | Common Stock | |
|
Health Catalyst Inc
|
Lee Kevin Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.45 per share. | 01 Dec 2023 | 2,921 | 167,810 (0%) | 0% | 7.5 | 21,762 | Common Stock |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.24 per share. | 01 Jun 2023 | 1,038 | 179,191 (0%) | 0% | 11.2 | 11,666 | Common Stock |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,819 | 179,665 (0%) | 0% | 0 | Common Stock | |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.29 per share. | 01 Mar 2023 | 1,569 | 177,846 (0%) | 0% | 14.3 | 22,419 | Common Stock |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,264 | 180,929 (0%) | 0% | 0 | Common Stock | |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.65 per share. | 01 Dec 2022 | 2,446 | 179,415 (0%) | 0% | 10.6 | 26,049 | Common Stock |
|
Health Catalyst Inc
|
Kevin Lee Freeman | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2022 | 120,000 | 181,861 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges